Chief Medical Officer · LeonaBio, Inc. (LONA)

Javier Martin

FY2025 is the first fiscal year CompBrief holds for Javier Martin as a named executive officer of LeonaBio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$810,134

Salary $500,000Stock awards $27,907Bonus $100,000

2nd of 3 named executive officers at LeonaBio by FY2025 total.

3 named officers on file for LeonaBio, FY2025

Javier Martin’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how LeonaBio’s whole pay program stands against its peers

  • LeonaBio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LONA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 11, 2026 (DEF 14A).

Free

Get Javier Martin’s full pay file as a PDF — free

More than this page: up to 10 years of Javier’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Javier Martin compensation by year

LeonaBio Summary Compensation Table · the one fiscal year held
In US dollars, as LeonaBio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$500,000
Bonus$100,000
Stock awards$27,907
Option awards$182,143
Non-equity incentive$0
Pension and deferred compensation$0
All other$85
Total$810,134

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LeonaBio, Inc. DEF 14A filed May 11, 2026, accession 0001193125-26-216742, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LeonaBio, Inc. filed document, accession 0001193125-26-216742. Every figure is read from that document and cited to the page and table it appears in. Filed May 11, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU7,418$56,154—
Option23,325—$20.60
Option9,039—$3.77
Option44,508—$4.07

Per the Outstanding Equity Awards at Fiscal Year-End table in LeonaBio, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

LeonaBio’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Mark LittonPresident and Chief Executive Officer$1,423,814
Javier Martin · this pageChief Medical Officer$810,134
Mark WorthingtonGeneral Counsel, Chief Compliance Officer and Corporate Secretary$731,477

The full LeonaBio compensation record

free company brief

This page is one person within LeonaBio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LeonaBio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Javier Martin's compensation dossier · One-time report. No refunds.